Abstract
Bcl-2 oncogene and Bax gene play an important role in regulating apoptosis. In the present study, the expression of bcl-2 and bax was investigated and correlated with apoptosis in a series of 81 pituitary adenomas. Bcl-2 and bax proteins were localized by immunohistochemistry and the histoscore (HSC) was assessed by multiplying the immunohistostaining grade (1 to 4) by the staining intensity grade (1 to 3). According to bcl-2/bax HSC the tumors were separated in group A when ≥1 and group B when <1. The apoptotic labeling index (ALI) was accessed by the in situ end-labeling (ISEL) technique. Bcl-2 protein was equally detected in functioning and nonfunctioning adenomas with statistically significant higher HSC in nonfunctioning tumors (P < 0.03). Bax protein was immunopositive in the substantial majority of adenomas with significantly higher HSC in functioning as compared to nonfunctioning adenomas (P < 0.0009). The ALI was significantly higher in functioning adenomas as compared to nonfunctioning adenomas (P < 0.04). In addition, ALI was significantly higher in group B than in group A (P < 0.004) and it was correlated with bax HSC (P < 0.004). Finally, the group B of bcl-2/bax significantly predominated in nonfunctioning tumors (P < 0.0009) and in microadenomas (P = 0.05), as compared with functioning adenomas and macroadenomas respectively. In conclusion, our findings suggest that bcl-2 and bax molecules play a role in the regulation of apoptotic mechanisms in pituitary adenomas.
Similar content being viewed by others
References
Tamm I, Schriever F, Dorken B. Apoptosis: Implications of basic research for clinical oncology. Lancer Oncol 2001;2: 33–42.
Kapranos N, Kontogeorgos G. Bcl-2 gene family in endocrine pathology: A review. Endocr Pathol 2000;11:205–213.
Korsmeyer SJ. Bcl-2: An antidote of programmed cell death. Cancer Surv 1992;15:105–118.
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132–1136.
Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis. Nature 1997;385:637–640.
Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996;86:147–157.
Korsmeyer SJ. Regulators of cell death. Trends Genet 1995;11:101–105.
Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD, Dorken B. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-á expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 1995;60:854–859.
Knudson CM, Tung K, Brown G, Korsmeyer SJ. Bax deficient mice demonstrate lymphoid hyperplasia but male germ cell death. Science 1995;270:96–99.
Rambino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967–969.
Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1–6.
Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 1994;369:321–323.
White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996;10:1–15.
Kontogeorgos G, Sambaziotis D, Piaditis G, Karameris A. Apoptosis in human pituitary adenomas: A morphologic and in situ end-labeling study. Modern Pathol 1997;10:921–926.
Vidal S, Horvath E, Kovacs K, Scheithauer BW, Lloyd RV, Kontogeorgos G. Ultrastructural features of apoptosis in human pituitary adenomas. Ultrastruct Pathol 2001;25:85–92.
Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, van Dierendonck JH. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7–12.
Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW. Null cell adenomas, oncocytomas and gonadotroph adenomas of the human pituitary: An immunocytochemical and ultrastructural analysis of 300 cases. Endocr Pathol 1993;4:20–27.
Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll J-L. Apoptosis-related factors p53, Bcl2 and Bax in neuroendocrine lung tumors. Am J Pathol 1996;149:1941–1952.
Wheaton S, Netser J, Ginee D, Rahn M, Perkins S. Bcl-2 and Cax protein expression in indolent versus aggressive ß-cell non-Hodgkin lymphomas. Hum Pathol 1998;29820–29825.
Sano T, Ohshima T, Yamada S. Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas. Pathol Res Pract 1991;187:530–533.
Cheung NW, Boyages SC. Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block. Endocrinology 1995;136:4174–4181.
Kulig E, Jin L, Qian X, Horvath E, Kovacs K, Stefaneanu L, Scheithauer BW, Lloyd RV. Apoptosis in nontumorous and neoplastic human pituitaries.Am J Pathol 1999;154:767–774.
Lee SY, Ahn BT, Baik SH, Lee BL. Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis. Neurosurgery 1998;43:116–123.
Srikant K. Cell cycle-dependent induction of apoptosis by somatostatin analog SMS201–996 in AtT-20 mouse pituitary cells. Biochem Biophys Res Commun 1995;209:400–406.
Yin D, Kondo S, Takeuchi J, Morimuta T. Induction of apoptosis in rat somatotropin-secreting adenoma cells by bromocriptine. Oncol Res 1993a;5:383–387.
Yin D, Kondo S, Takeuchi J, Morimuta T. Induction of apoptosis in rat ACTH-secreting adenoma cells by bromocriptine. FEBS Lett 1993b;339:73–75.
Ahlborn E, Grandison L, Zhivotovsky B, Ceccatelli S. Termination of lactation induces apoptosis and alters the expression of the Bcl-2 family members in the rat anterior pituitary. Endocrinology 1998;139:2465–2471.
Drewett N, Jacobi JM, Willgoss DA, Lloyd HM. Apoptosis in the anterior pituitary gland of the rat: Studies with estrogen and bromocriptine. Neuroendocrinology 1993;57:89–95.
Yonezawa K, Tamaki N, Kokunai T. Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat. Neurol Med Chir 1997;37:901–906.
Green VL, White MC, Hipkin LJ, Jeffreys RV, Foy PM, Atkin SL. Apoptosis and p53 suppressor gene protein expression in human pituitary adenomas. Eur J Endocrinol 1997;136:382–387.
Kontogeorgos G, Kapranos N, Thodou E, Sambaziotis D, Tsagarakis S. Immunocytochemical accumulation of p53 in corticotroph adenomas: Relationship with heat shock proteins and apoptosis. Pituitary 1999;1:207–212.
Wang DG, Johnston CF, Atkinson AB, Heaney AP, Mirakhur M, Buchanan KD. Expression of bcl-2 oncoprotein in pituitary tumours: Comparison with c-myc. J Clin Pathol 1996;49:795–797.
Saitoh Y, Arita N, Ohnishi T, Ekramullah S, Takemura K, Hayakawa T. Absence of apoptosis in somatotropinomas treated with octreotide. Acta Neurochir 1997;139:851–856.
Losa M, Barzaghi RL, Mortini P, Franzin A, Mangili F, Terreni MR, Giovanelli M. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: Comparison between micro-and macroadenomas. Am J Pathol 2000;156:245–251.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sambaziotis, D., Kapranos, N. & Kontogeorgos, G. Correlation of Bcl-2 and Bax with Apoptosis in Human Pituitary Adenomas. Pituitary 6, 127–133 (2003). https://doi.org/10.1023/B:PITU.0000011173.04191.37
Issue Date:
DOI: https://doi.org/10.1023/B:PITU.0000011173.04191.37